Anakinra - Wikipedia
Anakinra, sold under the brand name Kineret, is a biopharmaceutical medication used to treat rheumatoid arthritis, cryopyrin-associated periodic syndromes, familial Mediterranean fever, and Still's disease. [3] It is a slightly modified recombinant version of the human interleukin 1 receptor antagonist protein. [3]
Anakinra Uses, Side Effects & Warnings - Drugs.com
2024年10月31日 · Anakinra is used to treat the symptoms of moderate to severe rheumatoid arthritis in adults. Anakinra may also help slow the progress of the disease. Anakinra is usually given after other arthritis medications did not work or have stopped working.
Anakinra (Kineret): Uses & Side Effects - Cleveland Clinic
Anakinra is a medication that treats rheumatoid arthritis. This condition causes your immune system to attack the tissue lining your joints on both sides of your body. Anakinra can also treat other conditions that cause inflammation.
KINERET® (anakinra) Official Website | Home
KINERET® (anakinra) is a prescription medicine called an interleukin-1 receptor antagonist (IL-1Ra) used to: RA: Reduce the signs and symptoms and slow the damage of moderate to severe active rheumatoid arthritis (RA) in people aged 18 years and older when 1 or more other drugs for RA have not worked
Anakinra: MedlinePlus Drug Information
Anakinra is used alone or in combination with other medications to treat rheumatoid arthritis (condition in which the body attacks its own joints causing pain, swelling, and loss of function) in adults who were not helped by other disease-modifying antirheumatic drugs (DMARDs).
Anakinra: Uses, Interactions, Mechanism of Action - DrugBank …
Anakinra is a recombinant form of human interleukin-1 receptor antagonist used in the treatment of rheumatoid arthritis, neonatal-onset multisystem inflammatory disease and deficiency of interleukin-1 receptor antagonist (DIRA).
Anakinra (subcutaneous route) - Mayo Clinic
Anakinra injection is used alone or together with other medicines to treat signs and symptoms of moderately to severely active rheumatoid arthritis in patients who have previously received other medicines (eg, DMARDs) that did not work well.
Kineret: Uses, Dosage, Side Effects, Warnings - Drugs.com
2023年8月4日 · Kineret (anakinra) is classified as an interleukin antagonist. It works by blocking the activity of interleukin (IL-1), a substance in the body that can lead to pain, swelling and stiffness. Kineret is approved to treat rheumatoid arthritis and other inflammatory conditions.
KINERET® (anakinra) Official HCP Website | Home
KINERET ® (anakinra) is an interleukin-1 receptor antagonist indicated for: Rheumatoid Arthritis (RA). Reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis, in patients 18 years of age or older who have failed 1 or more disease-modifying antirheumatic drugs (DMARDs)
Kineret (anakinra) dosing, indications, interactions, adverse effects ...
Indicated for treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID), also known as chronic infantile neurologic cutaneous articular syndrome (CINCA) 1-2 mg/kg SC qDay...